๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Hodgkin's disease following non-Hodgkin's lymphoma

โœ Scribed by Lois B. Travis; Christopher L. Gonzalez; Benjamin F. Hankey; Elaine S. Jaffe

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
730 KB
Volume
69
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis

Although it is well known that the risk of non-Hodgkin's lymphoma (NHL) is elevated significantly after treatment for Hodgkin's disease,' an increased risk of Hodgkin's disease following NHL has not been noted in several large cancer registry Although descriptions of Hodgkin's disease following NHL have been reported oc~asionally,~-~ none have included estimates of risk. Delineation of the risk of Hodgkin's dis-From the

๐Ÿ“œ SIMILAR VOLUMES

Serum CA 125 is of clinical value in the
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma : Correlation with tumor parameters and disease activity
โœ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 30 KB ๐Ÿ‘ 3 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Serum CA 125 is of clinical value in the
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-hodgkin's lymphoma : Correlation with tumor parameters and disease activity
โœ Mario Lazzarino; Ester Orlandi; Catherine Klersy; Cesare Astori; Ercole Brusamol ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 116 KB ๐Ÿ‘ 3 views

## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen

T-cell lymphoma following Hodgkin's dise
T-cell lymphoma following Hodgkin's disease
โœ Gerald T. Gowitt; Wing C. Chan; Russell K. Brynes; L. Thompson Heffner ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 858 KB
Second cancers following non-Hodgkin's l
Second cancers following non-Hodgkin's lymphoma
โœ Lois B. Travis; Rochelle E. Curtis; John D. Boice Jr; Benjamin F. Hankey; Joseph ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 778 KB
Non-Hodgkin's lymphoma
Non-Hodgkin's lymphoma
โœ Timothy C. Greiner; L. Jeffrey Medeiros; Elaine S. Jaffe ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 1012 KB